Viewing Study NCT05781958


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-02-22 @ 7:23 PM
Study NCT ID: NCT05781958
Status: UNKNOWN
Last Update Posted: 2023-11-02
First Post: 2023-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC
Sponsor: Shen Feng
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intrahepatic Cholangiocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cadonilimab (anti-PD-1/CTLA-4 bispecific antibody) View